aod 9604 with semaglutide AOD-9604 Vial — Lyophilized, HPLC + COA AOD-9604 – Research Peptide |

Some use 300 mg daily, others explore doses up to 2,400 mg

GLP-1 receptor agonists have been shown in animal models to increase C-cell proliferation in the thyroid, raising the theoretical risk of malignancy in humans

Postpartum bodies often present a stack of issues, not one: lower-belly skin laxity, diastasis, residual breast changes, sometimes flank fat

If you accidentally use a U-40 syringe while dosing based on U-100 calculations, your draw will be 2.5 higher than intended

For pure weight loss, tirzepatide produces roughly a third more loss on average and has a slightly cleaner GI discontinuation profile in the only head-to-head trial that exists